Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Urology · Peking University First Hospital · Beijing

Dr. Gong Kan龚侃

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Gong Kan

Professional overview

Gong Kan is a Chief Physician and Professor in the Department of Urology at Peking University First Hospital, specializing in minimally invasive surgery and standardized, individualized management of urological malignancies.

SpecialtyUrology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentDepartment of Urology
HospitalPeking University First Hospital
CityBeijing
Hospital roleExecutive Deputy Director, Peking University Institute of Urology

Areas of focus

Prostate cancerIndividualized, standardized, and precise diagnosis and treatment, especially da Vinci robotic radical prostatectomy and individualized precision therapy
Renal cancerComprehensive management of sporadic and hereditary renal cancer, including robotic radical nephrectomy, partial nephrectomy, targeted therapy for advanced disease, and standardized diagnosis and treatment of VHL syndrome, BHD syndrome, etc.
Bladder cancerTransurethral resection of bladder tumor plus bladder-preserving comprehensive treatment, and da Vinci robotic radical cystectomy with urinary diversion
Upper urinary tract urothelial carcinomaDa Vinci robotic radical nephroureterectomy and bladder cuff excision
Adrenal tumorsAdrenalectomy
Benign prostatic hyperplasiaMinimally invasive surgical and medical treatment of complex and refractory cases

Background

  • 2010New Century Excellent Talent (Ministry of Education)
  • 2016Outstanding Scientific and Technological Innovation Leader (Ministry of Science and Technology)
  • 2017National High-Level Talent Support Program (Ten Thousand Talents Plan) (Organization Department of the CPC Central Committee)

Experience & recognition

  • Member of the editorial board of the Chinese Guidelines for Diagnosis and Treatment of Prostate Cancer
  • Consultant to the International VHL Alliance
  • Established China's only internationally certified center for hereditary renal cancer diagnosis and treatment
  • Built China's largest hereditary renal cancer database
  • Published over 80 SCI papers in journals including Cancer Discovery, Cancer Research, and Genetics in Medicine
  • Holds three national invention patents
  • Led multiple national research projects

Professional roles

  • Vice Chair, Urology Society, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
  • Member, Oncology Working Group, Urology Society, Chinese Medical Association (CMA)
  • Member, Urologic Oncology Committee, Chinese Medical Doctor Association (CMDA)
  • Standing Committee Member, Family and Hereditary Tumors Professional Committee, China Anti-Cancer Association (CACA)
  • Standing Committee Member, Oncology Professional Committee, Beijing Medical Association
  • Standing Committee Member, Rare Diseases Professional Committee, Beijing Medical Association

Frequently asked questions

What does Dr. Gong Kan specialize in?

Specializes in individualized, standardized, and precise diagnosis and treatment of complex urological malignancies—including prostate cancer, sporadic and hereditary renal cancer, bladder cancer, upper urinary tract urothelial carcinoma, adrenal tumors—as well as minimally invasive surgery and medical treatment for complex benign prostatic hyperplasia.

Which hospital and department is Dr. Gong Kan in?

Department of Urology at Peking University First Hospital

Sources

Dr. Gong Kan has not reviewed this page.